Contract Service Directory


Stock & Associates, Inc.





Company Headquarters

109 Bell Street
Seattle, WA 98155
United States

Contract Service Directory

    Related Content

    • Drug Delivery | Drug Development
      Inhaled Drug Delivery Technology Trends

      Inhaled Drug Delivery Technology Trends

      The success of new inhaled medicines relies on the correct combination of formulation and device technology.
      Dr. Sandy Munro, Vice President – Pharmaceutical Development, Vectura 11.24.20

    • Breaking News | Promotions & Moves
      Summit Therapeutics Appoints Chief Operating Officer

      Summit Therapeutics Appoints Chief Operating Officer

      Dr. Mahkam Zanganeh previously founded and led Maky Zanganeh and Associates consulting services firm.
      Contract Pharma Staff 11.23.20

    • Clinical Trials | Information Technology | R&D
      Decentralized Trials Fuel AI Revolution in Clinical Research

      Decentralized Trials Fuel AI Revolution in Clinical Research

      The life sciences industry is giving clinical a full makeover, dramatically improving how new therapeutics are developed.
      Nick Moss, Vice President of Analytics and Machine Learning, Medable 11.17.20


    • Breaking News | Industry News | Logistics
      Legacy Pharmaceutical Packaging Adds Facility for 3PL Ops

      Legacy Pharmaceutical Packaging Adds Facility for 3PL Ops

      Total footprint now exceeds 500,000 sq.-ft.
      Contract Pharma Staff 11.06.20

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      MolMed S.p.A Becomes AGC Biologics S.p.A

      MolMed S.p.A Becomes AGC Biologics S.p.A

      AGC Biologics now provides end-to-end cell and gene therapy CDMO services.
      Contract Pharma Staff 10.28.20

    • Financial Reports
      Financial Report: Biogen

      Financial Report: Biogen

      Revenues down 6% in the quarter to $3.4 billion.
      Contract Pharma Staff 10.26.20


    • Breaking News | Clinical Trials | Collaborations & Alliances
      Cytocom and Cleveland Biolabs Merge

      Cytocom and Cleveland Biolabs Merge

      Combine their businesses in an all-stock transaction.
      Contract Pharma Staff 10.20.20

    • Breaking News | Industry News
      Formulated Solutions Receives Three ISO Certifications

      Formulated Solutions Receives Three ISO Certifications

      Company is also pursuing ISO13485:2016 Medical Devices Quality Management Systems.
      Contract Pharma Staff 10.06.20

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
      GT Biopharma and Cytovance Biologics Expand Partnership

      GT Biopharma and Cytovance Biologics Expand Partnership

      Cytovance will be the exclusive GMP manufacture for three of the company's TriKE therapeutic product candidates.
      Contract Pharma Staff 10.06.20


    • Breaking News
      Covis Agrees to Acquire AMAG Pharmaceuticals

      Covis Agrees to Acquire AMAG Pharmaceuticals

      Expands its therapeutic portfolio of treatments.
      Contract Pharma Staff 10.01.20

    • Pharmaceutical Development for ADCs

      Pharmaceutical Development for ADCs

      Download the ADCs Poster.

    • Enhanced Delivery Options for Injectables

      Enhanced Delivery Options for Injectables

      Download the Enhanced Delivery Options Poster.


    • Promotions & Moves

      Akebia Therapeutics Names CMO

      Jain to lead clinical development of the company’s HIF pipeline
      05.25.17

    • APIs | Bioassay Development | Breaking News | Capsules | Drug Delivery | Drug Development | Industry News | Methods Development | Process Development | Solid Dosage/Semi-solids | Toxicology | Vials

      Recipharm Invests in Synthonics

      Will partner to develop new compounds
      04.14.15

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances

      GSK Bids for Human Genome Sciences

      HGS rejects $2.6 billion offer from Benlysta partner
      Gil Roth 04.19.12

    • Breaking News | Clinical Trials | CRO News

      Encorium Acquires Progenitor

      Builds vaccine-based CRO network
      07.19.10

    • Breaking News | Industry News

      Grifols To Acquire Talecris

      Barcelona-based Grifols SA will acquire Talecris Biotherapeutics Holdings Corp. for $3.4 billion in cash and stock, expanding its U.S. market share for blood-plasma products.
      06.07.10